Company record · updated August 5, 2026
Singular Genomics Systems, Inc.: 3 valuation observations from SEC filings
Every row below names the filing it came from. Coverage for this company runs May 7, 2021 to May 7, 2021.
3observations
1source filings
3verified rows
2021-05-07most recent as-of date
Source rails for this company: S-1 charter round (3).
| As of | Measure | Value | Reported by | Tier | What the filing says | Accession |
|---|---|---|---|---|---|---|
| 2021-05-07 | Series SEED price per share | 0.6901 USD | — | VERIFIED | "Original Issue Price" defined for Series SEED | 000119312521154963 |
| 2021-05-07 | Series B price per share | 2.3228 USD | — | VERIFIED | "Original Issue Price" defined for Series B | 000119312521154963 |
| 2021-05-07 | Series A price per share | 1.5465 USD | — | VERIFIED | "Original Issue Price" defined for Series A | 000119312521154963 |
Reading these figures
A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price. The capabilities page states the full limits.